Shilpa Medicare Share Price | Shilpa Medicare’s Recombinant Human Albumin 20% (rHA) is derived from yeast and offers a highly purified, structurally and functionally equivalent alternative to human serum albumin, the company said.
Shilpa Medicare gets nod to conduct Phase III clinical trials for Recombinant Human Albumin 20%
Share it
